1. Others
  2. Others
  3. RL71

RL71 is a curcuminoid anticancer agent that exhibits potent cytotoxicity against a variety of ER-negative breast cancer cells. RL71 (1 μM) induces cell cycle arrest in the G2/M phase and induces apoptosis in SKBr3 cells. RL7 also decreases HER2/neu phosphorylation and increases p27. RL71 also significantly reduced the phosphorylation of Akt and transiently increased the stress kinases JNK1/2 and p38 MAPK. Furthermore, RL71 exhibited anti-angiogenic potential in vitro, inhibiting the migration of HUVEC cells and the ability of these cells to form tubular networks.

For research use only. We do not sell to patients.

RL71 Chemical Structure

RL71 Chemical Structure

CAS No. : 1195795-93-7

Size Price Stock Quantity
Free Sample (0.1 - 0.5 mg)   Apply Now  
5 mg USD 75 In-stock
10 mg USD 120 In-stock
25 mg USD 240 In-stock
50 mg USD 380 In-stock
100 mg USD 540 In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

RL71 is a curcuminoid anticancer agent that exhibits potent cytotoxicity against a variety of ER-negative breast cancer cells. RL71 (1 μM) induces cell cycle arrest in the G2/M phase and induces apoptosis in SKBr3 cells. RL7 also decreases HER2/neu phosphorylation and increases p27. RL71 also significantly reduced the phosphorylation of Akt and transiently increased the stress kinases JNK1/2 and p38 MAPK. Furthermore, RL71 exhibited anti-angiogenic potential in vitro, inhibiting the migration of HUVEC cells and the ability of these cells to form tubular networks[1].

Cellular Effect
Cell Line Type Value Description References
A549 IC50
0.39 μM
Compound: 574
Antiproliferative activity against human A549 cells assessed as cell viability by WST-1 assay
Antiproliferative activity against human A549 cells assessed as cell viability by WST-1 assay
[PMID: 32172081]
A549 IC50
1.7 μM
Compound: 5B
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 29655083]
L02 IC50
26.4 μM
Compound: 5B
Cytotoxicity against human HL7702 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human HL7702 cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 29655083]
MDA-MB-231 EC50
0.3 μM
Compound: B10
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by SRB assay
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by SRB assay
[PMID: 20728364]
MDA-MB-231 IC50
0.39 μM
Compound: 574
Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability by WST-1 assay
Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability by WST-1 assay
[PMID: 32172081]
MDA-MB-468 EC50
0.3 μM
Compound: B10
Cytotoxicity against human MDA-MB-468 cells after 72 hrs by SRB assay
Cytotoxicity against human MDA-MB-468 cells after 72 hrs by SRB assay
[PMID: 20728364]
MDA-MB-468 IC50
0.39 μM
Compound: 574
Antiproliferative activity against human MDA-MB-468 cells assessed as cell viability by WST-1 assay
Antiproliferative activity against human MDA-MB-468 cells assessed as cell viability by WST-1 assay
[PMID: 32172081]
MG-63 IC50
0.39 μM
Compound: 574
Antiproliferative activity against human MG-63 cells assessed as cell viability by WST-1 assay
Antiproliferative activity against human MG-63 cells assessed as cell viability by WST-1 assay
[PMID: 32172081]
MV4-11 IC50
0.39 μM
Compound: 574
Antiproliferative activity against human MV4-11 cells assessed as cell viability by WST-1 assay
Antiproliferative activity against human MV4-11 cells assessed as cell viability by WST-1 assay
[PMID: 32172081]
NCI-H1650 IC50
1.5 μM
Compound: 5B
Cytotoxicity against human NCI-H1650 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human NCI-H1650 cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 29655083]
NCI-H1975 IC50
1 μM
Compound: 5B
Cytotoxicity against human NCI-H1975 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human NCI-H1975 cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 29655083]
NCI-H23 IC50
0.39 μM
Compound: 574
Antiproliferative activity against human NCI-H23 cells assessed as cell viability by WST-1 assay
Antiproliferative activity against human NCI-H23 cells assessed as cell viability by WST-1 assay
[PMID: 32172081]
NCI-H460 IC50
1 μM
Compound: 5B
Cytotoxicity against human H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay
[PMID: 29655083]
SK-BR-3 IC50
0.4 μM
Compound: B10
Cytotoxicity against human SKBR3 cells after 72 hrs by SRB assay
Cytotoxicity against human SKBR3 cells after 72 hrs by SRB assay
[PMID: 20728364]
Molecular Weight

469.53

Formula

C26H31NO7

CAS No.
Appearance

Solid

Color

Light yellow to yellow

SMILES

O=C1/C(CN(C/C1=C\C2=CC(OC)=C(C(OC)=C2)OC)C)=C/C3=CC(OC)=C(C(OC)=C3)OC

Shipping

Room temperature in continental US; may vary elsewhere.

Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Solvent & Solubility
In Vitro: 

DMSO : 100 mg/mL (212.98 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.1298 mL 10.6489 mL 21.2979 mL
5 mM 0.4260 mL 2.1298 mL 4.2596 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Purity & Documentation
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.1298 mL 10.6489 mL 21.2979 mL 53.2447 mL
5 mM 0.4260 mL 2.1298 mL 4.2596 mL 10.6489 mL
10 mM 0.2130 mL 1.0649 mL 2.1298 mL 5.3245 mL
15 mM 0.1420 mL 0.7099 mL 1.4199 mL 3.5496 mL
20 mM 0.1065 mL 0.5324 mL 1.0649 mL 2.6622 mL
25 mM 0.0852 mL 0.4260 mL 0.8519 mL 2.1298 mL
30 mM 0.0710 mL 0.3550 mL 0.7099 mL 1.7748 mL
40 mM 0.0532 mL 0.2662 mL 0.5324 mL 1.3311 mL
50 mM 0.0426 mL 0.2130 mL 0.4260 mL 1.0649 mL
60 mM 0.0355 mL 0.1775 mL 0.3550 mL 0.8874 mL
80 mM 0.0266 mL 0.1331 mL 0.2662 mL 0.6656 mL
100 mM 0.0213 mL 0.1065 mL 0.2130 mL 0.5324 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

RL71 Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
RL71
Cat. No.:
HY-121605
Quantity:
MCE Japan Authorized Agent: